60
Participants
Start Date
October 10, 2024
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2026
p16INK4a mRNA level assessment
Blood samples will be collected at two time points, plasma samples will be aliquoted, and T cells will be separated and expression of p16INK4a mRNA in peripheral blood T-lymphocytes will be determined
organ-specific protein signatures assessment
Blood samples will be collected at two time points, plasma samples will be aliquoted, and organ-specific protein signatures assessment will be determined.
RECRUITING
University of North Carolina, Chapel Hill
UNC Lineberger Comprehensive Cancer Center
OTHER